SHANGHAI and DUBLIN, Ireland, 28 March 2012 – PM Group is pleased to announce it has recently been awarded a series of new project management and design contracts with a capital value of over US$400m in China.
The announcement was made during the Enterprise Ireland trade mission to China which is being led by the Taoiseach Enda Kenny T.D. and the Minister for Jobs, Enterprise and Innovation Mr Richard Bruton T.D.
The contracts comprise a range of complex life science, medical technology, nutritional and food and beverage facilities for leading multi-national clients including: Abbott, Boston Scientific, GSK, HJ Heinz, Johnson & Johnson, Kraft and Cargill.
Welcoming the announcement the Taoiseach said:
“I am delighted to welcome this significant announcement by PM Group. The success of Irish companies like PM Group in highly competitive international markets sends a signal that we can compete with the best in the world. It is a testament to the ingenuity and innovation of Irish businesses and it gives me great confidence in our ability to recover by supporting Irish companies to create jobs and growth. I congratulate PM Group on their announcement today and wish them continued success.”
Niall O’Loughlin, General Manager – China, PM Group, added: “The recent projects we have won are a testament to our promise to provide our clients with the same high level of service regardless of location. Our growing reputation in China is a result of our focus on design excellence, safety and quality. Many of our recent projects in China represent repeat business from our key clients from the USA, Europe and Asia. We will continue to drive growth by providing our clients with the right service delivered locally and using our global expert base.”
According to CEO, Dave Murphy, PM Group chose China to capitalise on the opportunities that exist in one of the main regions where multinational corporations are investing today. He said, “We took a strategic decision to open an office in China as many of our leading multinational clients are investing there and have significant plans for further investment. We opened our new office in Shanghai to be able to serve the needs of those clients and it has proven to be a great location for us so far. We have been able to build a top class team there with extensive expertise in our core sectors of BioPharmaceutical, Food and Advanced Manufacturing.”